Picture of VG Life Sciences logo

VGLS VG Life Sciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for VG Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2010
December 31st
C2011
December 31st
R2012
December 31st
2013
December 31st
2014
December 31st
Period Length:
Source:PRESSARS10-Q10-Q10-K
Standards:
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.0070.0060.0060.7140.034
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.0160.0090.0060.7890.246
Net Property, Plant And Equipment0000
Net Intangible Assets
Long Term Investments
Total Assets3.13.091.081.871.32
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities3.142.815.286.335.83
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities5.114.155.987.036.49
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-2.01-1.06-4.9-5.17-5.17
Total Liabilities & Shareholders' Equity3.13.091.081.871.32
Total Common Shares Outstanding
Total Preferred Shares Outstanding